Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope.
Inherent Biosciences has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
Inherent Biosciences's investors include National Science Foundation, Portfolia, Kickstart, Propel Bio Partners, MedMountain Ventures.
Inherent Biosciences is headquartered in Salt Lake City, United States.
Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope.
Inherent Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inherent Biosciences — Funding & Investors." VCBacked, August 15, 2023, https://www.vcbacked.co/company/inherent-biosciences. Accessed September 29, 2026.
VCBacked. (2023). Inherent Biosciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/inherent-biosciences
{{cite web |title=Inherent Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/inherent-biosciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated